Showing results (51-60 of 82) with videos related to
Sort By:
Pageof 9
Lancet (London, England)|March 23, 2005
Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case reportMartin Markowitz, Hiroshi Mohri, Saurabh Mehandru, et al.Cancers|July 14, 2023
Identification of Tissue-Resident Natural Killer and T Lymphocytes with Anti-Tumor Properties in Ascites of Ovarian Cancer PatientsElin Bernson, Oisín Huhn, Veronika Karlsson, et al.BJU International|February 17, 2023
Urine supernatant reveals a signature that predicts survival in clear-cell renal cell carcinomaJorge Daza, Bérengère Salomé, Kennedy Okhawere, et al.Journal for Immunotherapy of Cancer|December 8, 2025
Immuno-oncologic profiling of renal masses using multiparametric MRI: a pilot studyMira M Liu, Octavia Bane, Xin Mu, et al.Biorxiv : the Preprint Server for Biology|September 21, 2023
Understanding the heterogeneity of alloreactive natural killer cell function in kidney transplantationDan Fu Ruan, Miguel Fribourg, Yuko Yuki, et al.Biorxiv : the Preprint Server for Biology|May 15, 2024
Natural Killer Cell Dysfunction In Human Bladder Cancer Is Caused By Tissue-Specific Suppression of SLAMF6 SignalingAdam M Farkas, Dina Youssef, Michelle A Tran, et al.Science Translational Medicine|October 25, 2013
Genetic and environmental determinants of human NK cell diversity revealed by mass cytometryAmir Horowitz, Dara M Strauss-Albee, Michael Leipold, et al.European Urology|October 9, 2022
Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non-muscle-invasive Bladder CancerTrine Strandgaard, Sia Viborg Lindskrog, Iver Nordentoft, et al.Med (New York, N.Y.)|May 19, 2022
A Systemic Protein Deviation Score Linked to PD-1<sup>+</sup> CD8<sup>+</sup> T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell LymphomaEivind Heggernes Ask, Astrid Tschan-Plessl, Thea Johanne Gjerdingen, et al.Scientific Reports|September 9, 2023
A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironmentCheng-Hsin Wei, Lu Huang, Blair Kreh, et al.Pageof 9